Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents

E-ISSN： 1873-4286|11|9|1131-1138

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.9, 2005-04, pp. : 1131-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len Neckers Katharine

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Novel chemotherapeutic agents for the treatment of brain cancer

By Newton H.B.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2815-2829

Informa Healthcare

Access to resources Recommend Favorite

Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives

By Kim TaeHun Keum Gyochang Pae Ae Nim

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 919-943

Informa Healthcare

Access to resources Recommend Favorite

Acridine Derivatives as Chemotherapeutic Agents

Current Medicinal Chemistry, Vol. 9, Iss. 18, 2002-09 ,pp. : 1655-1665

Bentham Science Publishers

Access to resources Recommend Favorite